Trastuzumab Completed Phase 3 Trials for Stage IV Breast Cancer / Her2-Positive Breast Cancer / Recurrent Breast Cancer / HER2-Negative Breast Cancer / Stage IIIC Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00003440Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic